Home
For Scientists
For Consumers
- Learn
- Infographics
- Videos
- Blog
For Students
For Clinicians
- Resources
  - Probiotics
For Members
- Becoming a Member
  - About Industry Membership
  - Content for members only
About ISAPP
Contact
Search
Menu Menu

ISAPP News

You are here: Home1 / News2 / ISAPP Comments on CBER Proposal on INDs

ISAPP Comments on CBER Proposal on INDs

May 28, 2015/in News /by Mary Ellen Sanders

May 28, 2015. ISAPP filed comments on an FDA-CBER proposal regarding CMC information required for INDs on probiotic research (Federal Register Notice). ISAPP welcomes this proposal by CBER that the label on a commercially available product would be adequate to satisfy CMC information. ISAPP comments.

Share this entry

Share on Facebook
Share on Twitter
Share on WhatsApp
Share on Pinterest
Share on LinkedIn
Share on Tumblr
Share on Vk
Share on Reddit
Share by Mail

https://isappscience.org/wp-content/uploads/2021/06/ISAPP_LogoRedsign_horz.png 0 0 Mary Ellen Sanders https://isappscience.org/wp-content/uploads/2021/06/ISAPP_LogoRedsign_horz.png Mary Ellen Sanders2015-05-28 00:00:002019-04-18 16:05:22ISAPP Comments on CBER Proposal on INDs